Sogroya® is the most prescribed once-weekly GH treatment.
As of January 2024
Novo Nordisk is a leader in the growth hormone market, with more than 25 years of expertise.
Unleash their potential with once-weekly Sogroya® growth hormone treatment. Sogroya® promotes growth—with 1 injection per week.
You may be relieved to learn that Sogroya® is covered by CVS Caremark®, TRICARE®, Florida Medicaid, MedImpact / Elixir, Anthem Blue Cross Blue Shield, and Aetna®. Get more information about support programs as you begin your GH journey.a
aIndividual benefit designs and individual coverage may vary. Because many health plans offer more than one formulary, check directly with your health plan to confirm coverage.
Actor portrayal
Actor portrayal
Are you an adult living with AGHD?
Leave the once-daily baggage behind with Sogroya®. The first and only once-weekly treatment for adult growth hormone deficiency (AGHD).
Need help planning injections?
The Sogroya® Smart Scheduler will help you manage your injection days, including split doses.
Designed with you in mind
The Sogroya® pen is ready to use. It’s prefilled and doesn’t require cartridges or preparation of the medicine.
Updates and helpful information
Tips and suggestions
Support, including patient resources